Shared on07 Aug 25Fair value Increased 5.09%
Clariane’s fair value has been revised upward as improving net profit margin outweighed the impact of a higher discount rate, resulting in the consensus price target rising from €4.91 to €5.16. What's in the News Clariane SE expects organic sales growth of around 5% for 2025, supported by strong momentum in France and Germany, with ramp-up contributions in the Netherlands and Spain.
Shared on29 Jul 25Fair value Increased 8.35%
Clariane’s higher future P/E ratio and improved net profit margin signal increased market confidence in its earnings outlook, supporting the consensus analyst price target increase from €4.53 to €4.91. Valuation Changes Summary of Valuation Changes for Clariane The Consensus Analyst Price Target has risen from €4.53 to €4.91.